This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biorec S.a., Centro De Ingenieria Genetica Y Biotechnologia. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 15 Years Active: 2016
Title: Humberto Lamdan Ordas: Innovator in Recombinant Antibodies
Introduction
Humberto Lamdan Ordas is a notable inventor based in Artemisa, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. His work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Humberto holds a patent for "Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regions." This invention reveals human recombinant antibodies that recognize the human Vascular Endothelium Growth Factor A (VEGF-A). These antibodies block the interaction with the VEGFR2 receptor and interfere with its proliferative effect in vitro and pro-angiogenic effect in vivo. The antibodies identify a unique epitope on human VEGF-A, different from any previously reported. They were obtained by combining one immunoglobulin light chain variable region with three heavy chain ones. The antibodies can be employed for the immunotherapy of pathological entities associated with increased vasculature, such as age-related macular degeneration and cancer.
Career Highlights
Humberto has worked with prominent organizations in the biotechnology sector. He has been associated with the Centro de Ingeniería Genética y Biotecnología and Biorec S.A. These experiences have enriched his expertise and contributed to his innovative work in recombinant antibodies.
Collaborations
Humberto has collaborated with notable professionals in his field, including Jorge Victor Gavilondo Cowley and Marta Ayala Avila. These collaborations have played a crucial role in advancing his research and development efforts.
Conclusion
Humberto Lamdan Ordas is a distinguished inventor whose work in recombinant antibodies has the potential to impact various medical fields significantly. His innovative approach to addressing health challenges showcases the importance of research and development in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile